Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-09

Clinical Trial Update: The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the effect of sarpogrelate combined with high-dose statin on reducing coronary spasm in variant angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarpogrelate (sarpogrelate)
  • Statin (high-dose) (statin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Variant Angina | Phase 4 | Status: UNKNOWN